Latest papers

Drug-related acute and chronic hepatitis.

[Oxyphenisatin, a laxative responsible for chronic hepatitis and cirrhosis, still marketed in France (author's transl)].

[Drug-induced active hepatitis (author's transl)].

[Chronic active hepatitis in patients taking phenlaxin-containing lexatives].

Drug-induced chronic hepatic disease.

[Morphological findings in liver lesions in persons taking phenlaxine-containing laxatives].

Studies in the rat on the absorption, biliary excretion, laxative action and interference with intestinal transport of some oxyphenisatin derivatives.

Current concepts of laxative action: mechanisms by which laxatives increase stool water.

Drug-induced chronic hepatitis and cirrhosis.

Comparison of the effect of drugs upon some commonly used measures of bowel transit time.

Study of the comparative effectiveness of Dulcolax, Laxadine, Dorbanex, Normacen and Senokot laxatives in the bowel preparation of patients for radiological examinations.

Diphenolic laxatives and intestinal cAMP: experiments with oxyphenisatine in the rat in vivo.

[Clinical aspects of chronic hepatitis. Diagnosis and differential diagnosis].

[Field study: results of treatments with Laxos in general practice]

Outcome of chronic active hepatitis: influence of histocompatibility antigens and triggering factors.

[Drug-induced chronic aggressive hepatitis].

[Failure of oral contraception--probably because of interaction with phenemal].

Safety of stool softeners.

Drug-induced chronic liver disease.

Transfer of sodium and water through isolated rat colonic mucosa under the influence of deoxycholate and oxyphenisatin.